The corecognition of antigen and class II major histocompatibility complex (MHC) molecules (Ia molecules) by the T-cell receptor is a cell surface event. Before antigen is recognized, it must be taken up, processed, and displayed on the surface of an Ia-bearing accessory cell (antigen-presenting cell, APC). The exact nature of antigen processing and the subsequent associations of antigen with the APC plasma membrane, Ia molecules, and/or the T-cell receptor are not well defined. To further analyze these events,
receptor are not well defined. To further analyze these events, we have characterized the processing and presentation of the soluble polypeptide antigen bovine insulin. We found that this antigen requires APC-dependent processing, as evidenced by the inability of metabolically inactivated APCs to present native antigen to antigen plus Ia-specific T-T hybridomas. The ability of the same APCs to present antigen after uptake and processing showed that this antigen subsequently becomes stably associated with the APC plasma membrane. To characterize the basis for this association, we analyzed its sensitivity to enzymatic digestion. APCs exposed to antigen, treated with phospholipase A2, and then immediately fixed lost the ability to stimulate bovine insulin plus I-Ad-specific hybridomas. In contrast, the ability of these same APCs to stimulate I-Ad allospecific hybridomas was unaffected. This effect of phospholipase is not mimicked by the broadly active protease Pronase, nor is there evidence for contaminating proteases in the phospholipase preparation. These results suggest that one consequence of antigen processing may be an antigen-ipid association that contributes to the anchoring of antigen to the APC membrane. The implications of this model are discussed.
The activation of inducer T lymphocytes by foreign antigen requires the corecognition of antigen in association with class II major histocompatibility complex (MHC) molecules (Ia molecules) (1, 2) . Corecognition is a cell surface event (3) , mediated by a single clonotypic T-lymphocyte receptor (4) . However, the precise molecular interactions occurring between antigen, the antigen-presenting cell (APC) plasma membrane, Ia molecules, and the T-cell receptor are not well defined.
Prior to recognition, native antigen must be taken up and processed by an APC (5) . Operationally, antigen processing is defined as the conversion of a native, nonstimulatory protein to an immunogenic form. The requirement for antigen processing can be bypassed by denaturation and/or limited proteolysis of the antigen in several systems (5) (6) (7) . Recent analysis has suggested that immunogenic antigen fragments share a common amphipathic structure (8) . Cell-processed antigen has not been directly characterized and its structure is inferred solely from in vitro reconstitution experiments. In vivo processing has been shown to be important for the molecular interaction of antigen with the APC surface (9) . It has been proposed that antigen, or its processed fragment, can associate specifically with class II MHC molecules on the surface of an APC (10, 11) . Evidence supporting such an association has been reported by several laboratories, including our own (12) (13) (14) (15) (16) . This antigen-Ia interaction does not appear to be generally of sufficient affinity to explain the stable binding of antigen to the APC-membrane; therefore, there must be additional interaction of antigen with membrane structures. Further, the nature of this association must be applicable to all protein antigens, since APCs can process and present an unlimited number of diverse antigens. The present study was initiated to analyze the mechanism by which an APC converts an initially soluble protein to a membrane-associated antigen.
MATERIALS AND METHODS
Reagents. Bovine insulin, bovine serum albumin, Pronase (Streptomyces griseus protease), and lyophilized phospholipase A2 purified from Naja naja venom were obtained from Sigma. The phospholipase A2 preparations were purified by acid and heat (100°C, 10 min) denaturation/renaturation and ion-exchange and gel-exclusion chromatography by the manufacturer.
T-Cell Hybridomas. The alloreactive, I-Ad-specific hybridoma RF19.52 has been characterized previously (15) were incubated in serum-free RPMI with phospholipase A2 (10 units/ml), with or without bovine serum albumin (2 mg/ml), for 1 hr at 37°C and then immediately fixed. Pronase (100 ,ug/ml) treatments were done in an identical fashion.
T-cell hybridoma cultures were incubated at 37°C for 18-24 hr. One hundred microliters of supernatant was then removed, exposed to y radiation (8000 rads; 1 rad = 0.01 Gy), and assayed for IL-2 content as described (9) . Data are expressed as the arithmetic mean cpm incorporated by duplicate cultures.
Immunofluorescence. Indirect immunofluorescence staining was performed as described (20) 
RESULTS
To analyze the events of antigen processing and presentation, we have characterized T-cell responses to a polypeptide hormone, bovine insulin. This antigen was chosen because its structure is extremely well defined, as are the genetics and specificity of T-cell responses to its species variants (21, 22) .
We assessed whether this low molecular weight protein requires processing by comparing the ability of untreated or metabolically inactive APCs to present the native antigen. Presentation was measured by the ability of antigen-exposed APCs to stimulate IL-2 production by bovine insulin-specific, MHC-restricted T-cell hybridomas.
As shown in Table 1 , live APCs can present soluble insulin. Furthermore, if the APCs are incubated with native protein and then washed, the small amount of cell-associated antigen is sufficient to stimulate a T-cell response. In contrast, the inactivated APCs are unable to present native antigen, even when added in vast excess. If, however, these cells are first allowed to take up and process insulin and then fixed, they are capable of stimulating the specific T-cell hybridoma. This indicates that fixation does not affect presentation events subsequent to antigen processing. These results indicate that insulin requires a processing step that is sensitive to metabolic inactivation. This is consistent with findings for most conventional protein antigens (5) . For insulin, this processing requirement is not circumvented by in vitro heat denaturation and/or trypsin digestion (unpublished data). Furthermore, isolated bovine insulin A and B chains will not stimulate this hybridoma in the presence of either live or fixed APCs (unpublished data). These observations suggest that extensive degradation is not the essential processing event for this protein.
The ability of fixed APCs to present processed insulin demonstrates that this immunogen is accessible to the T cell on the APC surface. To characterize the basis for the cell surface association of this antigen, we analyzed its sensitivity to enzymatic digestion. For this purpose, we incubated APCs with bovine insulin for 18 hr, during which time they took up, processed, and displayed immunogenic insulin on their cell surface (Table 1) . These cells were then treated with various enzymes and immediately fixed to prevent antigen reexpression.
Treatment with the enzyme phospholipase A2 significantly reduces the ability of antigen-exposed APCs to stimulate IL-2 production by the bovine insulin plus Ia-restricted T-cell hybridoma (Fig. 1A) . In contrast, the same APCs show no difference in their ability to stimulate an allospecific hybridoma whether or not they have been treated with phospholipase (Fig. 1B) . This differential effect of phospholipase treatment on the antigen-specific vs. the allospecific response is observed even under limiting conditions. The ability of phospholipase-treated APCs to stimulate an allospecific response suggests that the enzyme treatment does not disrupt any essential component of APC-T-cell interaction. Further, the allospecific hybrid is stimulated by precisely the same Ia molecule that is corecognized by the bovine insulin plus Ia-specific hybrid. Therefore, treatment has not affected the function of the relevant La molecules on the surface of the APC.
Since the immunogen is a protein, it was important to rule out the potential effect of proteases that might contaminate the phospholipase preparation, even though the preparation had been purified extensively. Several observations make such effects unlikely. First, as shown in Fig. 2 , the phospholipase effect on antigen presentation is observed in the presence of bovine serum albumin (2 mg/ml), which Cultures were incubated and supernatants were assayed for IL-2 content as described in the legend to Table 1 . APCs, no. Pronase has broad specificity and is highly active at the concentrations employed, as shown by its ability to digest the APC integral membrane protein LFA-1 (lymphocyte function-associated antigen 1) (Fig. 3) . Second, phospholipase A2 activity is unusually insensitive to heat denaturation (23) . The enzyme preparations have been heated during purification (by the manufacturer) and retain activity. Any potential contaminating enzymes would be expected to be inactivated. As shown in Fig. 3, heat It appears unlikely that antigen-Ia interaction is the sole basis for the membrane association of antigen. The affinity of such interaction is thought to be relatively low (16, 24) . In addition, the turnover of surface Ia is more rapid than the apparent persistence of cell surface antigen (25) . Finally, the association of antigen with the plasma membrane is not easily saturable and does not appear to be the site of competition (9, 13). Although we feel that specific antigen-Ia interaction is necessary for the presentation of many antigens, these considerations suggested to us that antigen is not primarily anchored through such an association.
In the present study, we investigated the presentation of bovine insulin. This antigen requires processing and is subsequently displayed on the surface of APCs that have been exposed to Physiologically processed antigen has not been isolated. Its structure is inferred solely from the observation that processing can be circumvented by protein denaturation and/or degradation in vitro (5) . While it is likely that such events are important in vivo, it remains to be determined whether these are the only modifications that occur. Treatment with lipases may be a suitable approach to release processed antigen in amounts allowing characterization.
Precisely why processing is required is not completely understood. Molecular alterations of antigen may be necessary for its interaction with the APC membrane, Ia molecules, and/or the T-cell receptor. There is limited evidence that processing may be of importance for each of these. T-cell reactivity is primarily directed to determinants found on unfolded or fragmented molecules (5) . Processing that affects determinants thought to interact with the T-cell receptor has been described for the antigen cytochrome c (31) . We have previously shown that processing is important for the interaction of copolymer antigens with Ia molecules on the APC surface (9) . It seems likely that processing will affect all of the above interactions in at least some systems. Recent analysis of many immunogenic peptide fragments has revealed the common structural feature of amphipathicity, and it has been suggested that this is important for the interaction of antigen with the above structures (8) . This latter feature is of interest given our present results.
The model we propose, wherein processing results in antigen-lipid association, would have several consequences. It would explain the stability of membrane-associated antigen and the availability of nonsaturable association sites. It would predict that an APC would bear on its surface a sample of the numerous antigens, both foreign and autologous, to which it has recently been exposed. Furthermore, such antigens would be highly mobile. This property, along with the concentration of antigen in the plane of the membrane, would facilitate interactions with integral membrane proteins such as Ia (32) .
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